Kotak Small Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Kotak Small Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Kotak Small Cap Fund - Direct (G)

2.24%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

Deutsche Bank, AG Standard Chartered Bank

Computer Age Management Services (P) Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

18690.79

2.02

316.03

January 1, 2013

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

13.89 %

13.45 %

2.24 %

14.01 %

19.35 %

7.4 %

Harish Bihani

MBA in Finance

Prior to joining ICICI Prudential Mutual Fund, he has worked with SBI Mutual Fund, Kotak Instituitional Equities, CIMB Securities, RBS Equities India Pvt. Ltd., Indiabulls Securities Ltd. and Reliance Equities International Pvt. Ltd.

Pankaj Tibrewal

B.Com., MFM from Manchester University.

He has over 5 years of experience in managing funds. Prior to joining Kotak Mahindra AMC, has been with Principal PNP Asset Management co p ltd as fund manager.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right